← Eichor
Condition: Nodular Lymphocyte Predominant Hodgkin Lymphoma Synced from ClinicalTrials.gov · July 29, 2026

Recruiting studies: Nodular Lymphocyte Predominant Hodgkin Lymphoma

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Comparing the Effectiveness of the Immunotherapy Agents Rituximab or Mosunetuzumab in Patients With Nodular Lymphocyte-P
Phase 2 · 37 location(s) · National Cancer Institute (NCI) · NCT05886036Patient-Reported Outcomes and Quality of Life in Adult and Pediatric Patients With Nodular Lymphocyte-Predominant Hodgki
Phase N/A · 7 location(s) · St. Jude Children's Research Hospital · NCT06098430
Look up another condition
Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.